Sign in
TerminatedNo phase

Impact of Providing Medical Records in a Patient-Centered, Community Pharmacy Based, HIV Care Model (HIV-MOI)

Key facts

Who runs it
University of North Texas Health Science Center
Where
Fort Worth, United StatesSee the 2 sites
Trial code
Status
Terminated
People taking part
129 people enrolled
Started
3 Aug 2018
Ended
27 Feb 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Medication optimization intervention
Record updated
18 July 2025
Why it stopped
Recruitment and funding challenges

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • 18 years of age or older
  • African-American
  • HIV positive
  • At least one of the following: hypertension or diabetes type 2

Who cannot take part

  • Have a life expectancy < 2 years
  • Pregnant (at screening, may enroll 6 months post-delivery)
  • Refusal to provide medical record release

Where in United States

  • Crystal HodgeFort Worth, United States
  • University of North Texas Health Science CenterFort Worth, United States

About the trial

What the trial wants to find out

This is a clinical trial. The purpose of this clinical trial is to see if study participants have better health outcomes if their pharmacist has access to their medical records. The study will take place primarily in Fort Worth and Dallas, Texas. The trial will enroll adult, African-Americans with HIV. Study participants must also have either diabetes, high blood pressure or they may have both. Study participants will agree to have their medical records from all of their health providers released to UNTHSC. UNTHSC will provide the study pharmacist the medical records for half of the participants. Using the medical records, the study pharmacist will provide 'enhanced' patient counseling services to half of the participants. This enhanced service is called 'medication optimization'. For half of the participants that the study pharmacist does not see the medical records, they will receive usual and customary patient counseling. Not seeing the medical records is considered standard of care. In both groups, the counseling frequency will be based on the participant's needs but the study pharmacist will contact every participant to check on them at least every 90 days. These visits will happen for 2 years. The two groups will be compared to see if those participants having medical information supported medication optimization have better health than those getting routine, the standard of care medication optimization.

The 2 groups in the trial

  • Medication Optimization InterventionTreatment being tested

    This group will represent those participants whose medical records have been provided to the pharmacist.

  • Medication Optimization ControlExisting treatment, for comparison

    This group will represent those participants whose medical records have not been provided to the pharmacist.

    Treatment: Medication optimization intervention

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Assessing the Impact of Providing Pharmacists With Medical Records in a Patient-Centered, Community Pharmacy-Based, HIV Care Model
Record updated
18 July 2025